학술논문
Randomized Phase II study of first-line docetaxel (D)/gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC) - Final Results. A study by the NSW and Australian Lung Cancer Trials Group
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
18728332